Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.5M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+92.3K
-
Total reported value, excl. options
-
$77.9M
-
Value change
-
+$211K
-
Number of buys
-
16
-
Number of sells
-
-29
-
Price
-
$4.09
Significant Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q2 2022
54 filings reported holding HOWL - Werewolf Therapeutics, Inc. - Common Stock as of Q2 2022.
Werewolf Therapeutics, Inc. - Common Stock (HOWL) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 48.5M outstanding shares and own 39.27% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.29M shares), MPM ASSET MANAGEMENT LLC (4.28M shares), BIOIMPACT CAPITAL LLC (2.39M shares), PFM Health Sciences, LP (1.73M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (958K shares), SPHERA FUNDS MANAGEMENT LTD. (597K shares), DC Funds, LP (589K shares), Laurion Capital Management LP (535K shares), and FMR LLC (519K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.